Bio Protocol Enters V2 Phase, Users Can Earn BioXP Through Staking
Foresight News reports that Bio Protocol has entered the V2 phase and launched Launcher V2, allowing users to sell low-market-cap BioAgents, IP-Tokens, and BioDAOs. In addition, users can stake BIO and DeSci tokens to earn BioXP, and accumulate points by participating in activities. These points can be used to access new sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CNN Enters Generative AI Partnership with Google
US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening
As of press time, the stock is up more than 11%, trading at $17.77.
US Stock Market Movement | 3D Printing Materials Supplier Amaero (AMRO.US) Debuts on US Stock Market, Trading Halt Triggered After Opening
Amaero, a manufacturer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, has gone public on the US stock market.
Crypto prices
More
